Ishita Drugs & Industries Ltd. submitted a confirmation certificate for securities dematerialisation and listing compliance for the quarter ended September 30, 2024, as required by SEBI Regulations.
AI Assistant
Ishita Drugs & Industries Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.